Accordingly, the downstream pathway targets of c-Myc as well as those of cyclins D1 and D2 (e.g. pRb, cyclin A2 and cyclin B1) were also downregulated and contributed to the anti-cancer activity of tylophorine. The gene discussed is CCNA2; the disease is cancer.